Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Product › Details

AAV-RPE65 gene therapy (MeiraGTx)

	Next higher product group	gene therapy_o
	Status	2019-03-26 development p2 existent
	Organisation	MeiraGTx Holdings Plc (NASDAQ: MGTX)
	Group	MeiraGTx (Group)
	Source	MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY.

Record changed: 2024-06-07

Picture Kenes Exhibitions Biomed Israel 2025 Tel Aviv 650x200px

More documents for gene therapy_o

[1] Genespire S.r.l.. (5/9/24). "Press Release: Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting". Milan....
[2] Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund....
[3] Orchard Therapeutics plc. (1/24/24). "Press Release: Kyowa Kirin Successfully Completes Acquisition of Orchard Therapeutics, a Global Gene Therapy Leader for Rare Diseases". Tokyo, London & Boston, MA....
[4] MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY....
[5] Orchard Therapeutics plc. (10/5/23). "Press Release: Kyowa Kirin to Acquire Orchard Therapeutics". Tokyo, London & Boston, MA....
[6] Kate Therapeutics Inc.. (6/8/23). "Press Release: Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430"....
[7] Kate Therapeutics Inc.. (6/8/23). "Press Release: Kate Therapeutics Debuts with $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases"....
[8] Uniqure N.V.. (5/15/23). "Press Release: Uniqure Announces Sale of Royalty Interest in Hemgenix for up to $400 Million". Lexington, MA & Amsterdam....
[9] Sio Gene Therapies Inc.. (1/31/22). "Press Release: Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO Transition". New York, NY & Durham, NC....
[10] Genenta Science S.p.A.. (12/17/21). "Press Release: Genenta Closes Its Upsized Initial Public Offering of American Depository Shares". Milan & New York, NY....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]